About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Attacking Melanoma With a Combination Therapy

by Anjali Aryamvally on April 20, 2018 at 3:51 PM
Font : A-A+

Attacking Melanoma With a Combination Therapy

Two drugs designed to boost T cell performance, when given in combination may enhance the immune system's ability to kill melanoma tumors deficient in the tumor suppressor gene PTEN. The pre- clinical study of the two drugs was led by investigators at The University of Texas MD Anderson Cancer Center.

The study combined OX40 agonist antibody and GSK2366771. OX40 is a protein critical to cell signaling required for T cells to fully function; while OX40 agonist antibodies are drugs that make the process more efficient. GSK236671 is an investigational drug that inhibits a pathway often linked to cancer called PI3K. Together, the agents appear to be the cellular equivalent of stepping on the gas, revving up T cells and providing the extra power they need to more efficiently kill cancer cells.

Advertisement


Study findings were presented today at the American Association for Cancer Research Annual Meeting 2018 in Chicago. The study results builds on prior investigations by the research team which demonstrated that activation of the PI3K pathway by PTEN tumor loss created a "microenvironment" allowing tumors to evade immune suppression.

"In our latest study, results suggest that the combination of an OX40 agonist antibody and GSK2636771 may induce robust and durable antitumor T-cell immunity," said Weiyi Peng, M.D., Ph.D., assistant professor of Melanoma Medical Oncology, and co-lead of the study. "These results also provide a rationale to explore the clinical activity of an OX40 agonist antibody in combination with GSK2636771 in cancer patients with PTEN loss tumors."
Advertisement

PTEN loss occurs in many cancers including breast, colorectal, prostate and others. By using a genetically engineered mouse model of melanoma, the team was able to spontaneously develop tumors with PTEN loss, and observe the combination therapy.

"We saw significantly delayed tumor growth and improved survival time of mice bearing PTEN loss tumors," said Patrick Hwu, M.D., division head of Cancer Medicine and principal investigator of the study. "This combinational treatment also was well tolerated and enhanced the number of CD8 T cells at the tumor site. These results suggest GSK2636771 treatment can 'synergize' with OX40 agonist antibodies to augment effector functions of tumor-reactive T cells."

To confirm this synergistic effect, the team measured serum levels of signaling proteins in tumor-bearing mice receiving OX40 agonist antibodies alone or in combination with GSK2636771. Serum levels of proteins secreted by powerful memory or effector T cells, which are longer lasting and more capable of "remembering" cancer cells, were significantly increased in the combination therapy versus OX40 agonist antibody alone.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Sensory Processing Disorder (SPD)
First Dose of COVID-19 Vaccines May Improve Mental Health
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Skin Cancer Ultra-Violet Radiation Reiki and Pranic Healing Amyotrophic Lateral Sclerosis (ALS) Melanoma Combination Therapy for High Blood Pressure Acute Coronary Syndrome 

Recommended Reading
Melanoma
Melanoma is a dangerous form of skin cancer caused largely due to exposure to the sun's damaging UV ...
New Compound Identified Can Inhibit Melanoma Cell Growth
Corin, a novel compound identified targets specific epigenetic modifying proteins in tumor cells ......
New Treatment Could Keep Melanoma at Bay
Changing schedules of drug administration for melanoma can improve outcomes leading to more ......
Novel Study Finds a Way to Prevent Melanoma Metastasis
Leukemia drugs may target cathepsins (enzymes highly expressed in cancer cells) and can prevent the ...
Acute Coronary Syndrome
Acute coronary syndrome (ACS) is a sudden, acute life-threatening condition caused by a dramatic red...
Amyotrophic Lateral Sclerosis (ALS)
Find out more about the degenerative disease- Amyotrophic lateral sclerosis....
Combination Therapy for High Blood Pressure
Anti-hypertensive agents are still the treatment drugs for hypertension but recent advances indicate...
Skin Cancer
Skin cancer is an abnormal growth of skin cells. It can develop due to a continuous exposure to sun ...
Ultra-Violet Radiation
Ultraviolet radiations are electromagnetic radiations with wavelengths shorter than the shortest wav...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use